A phase II randomized trial of cisplatin/paclitaxel plus lonidamine versus cisplatin/ifosfamide plus lonidamine in the treatment of ovarian cancer Background: Epidermal Growth Factor Receptor (EGFR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback